Targeted Therapy Database (TTD): A Model to Match Patient's Molecular Profile with Current Knowledge on Cancer Biology

• Simone Mocellin ,

  * E-mail: simone.mocellin@unipd.it

  Affiliation Clinica Chirurgica Generale 2, Department of Oncological and Surgical Sciences, University of Padova, Padova, Italy

  ⨯
• Jeff Shrager,

  Affiliation Symbolic Systems Program, Stanford University, and CollabRx, Inc., Palo Alto, California, United States of America

  ⨯
• Richard Scolyer,

  Affiliations Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia, Melanoma Institute Australia, Sydney, Australia, Discipline of Pathology, The University of Sydney, Sydney, Australia

  ⨯
• Sandro Pasquali,

  Affiliation Clinica Chirurgica Generale 2, Department of Oncological and Surgical Sciences, University of Padova, Padova, Italy

  ⨯
• Daunia Verdi,

  Affiliation Clinica Chirurgica Generale 2, Department of Oncological and Surgical Sciences, University of Padova, Padova, Italy

  ⨯
• Francesco M. Marincola,

  Affiliation Infectious Disease and Immunogenetics Section, Department of Transfusion Medicine, Clinical Center, and Center for Human Immunology, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Marta Briarava,

  Affiliation Clinica Chirurgica Generale 2, Department of Oncological and Surgical Sciences, University of Padova, Padova, Italy

  ⨯
• Randy Gobbel,

  Affiliation Symbolic Systems Program, Stanford University, and CollabRx, Inc., Palo Alto, California, United States of America

  ⨯
• Carlo Rossi,

  Affiliation Clinica Chirurgica Generale 2, Department of Oncological and Surgical Sciences, University of Padova, Padova, Italy

  ⨯
• Donato Nitti

  Affiliation Clinica Chirurgica Generale 2, Department of Oncological and Surgical Sciences, University of Padova, Padova, Italy

  ⨯